Nj State Employees Deferred Compensation Plan Abbott Laboratories Transaction History
Nj State Employees Deferred Compensation Plan
- $824 Million
- Q3 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Abbott Laboratories stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 32,854 shares of ABT stock, worth $3.75 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
32,854
Previous 32,854
-0.0%
Holding current value
$3.75 Million
Previous $3.41 Million
9.73%
% of portfolio
0.45%
Previous 0.43%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.76 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.51 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...